Study explores industry connections on guidelines committees

08/15/2013 | MedPage Today (free registration)

About 75% of the members of panels setting definitions and diagnosis guidelines for 14 diseases had connections to drugmakers marketing or developing products for the same conditions, a study published in PLOS Medicine found. Members of 12 panels disclosed ties to more than one company, and only the panel changing the definition of type 2 diabetes disclosed no financial ties, researchers found.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD